Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23503922 | 0.80 | KDM4E (0.41) | ALDH1A1ALOX15MAPK10HSD17B10KDM4E | |
| SCHEMBL20539129 | 0.79 | BCHE (0.42) | ALDH1A1ALOX15KDM4EGAAMAPT | |
| SCHEMBL23504162 | 0.79 | — | — | |
| SCHEMBL23503791 | 0.79 | — | — | |
| SCHEMBL22472524 | 0.77 | EGFR (0.32) | GAAMAPT | |
| SCHEMBL22472506 | 0.77 | ALDH1A1 (0.32) | ALDH1A1ALOX15MAPK10HSD17B10 | |
| SCHEMBL26535672 | 0.76 | ALDH1A1 (0.47) | ALDH1A1ALOX15MAPK10HSD17B10KDM4E | |
| SCHEMBL11990885 | 0.71 | ALDH1A1 (0.39) | ALDH1A1ALOX15KDM4EGAAMAPT | |
| SCHEMBL30996985 | 0.71 | ALDH1A1 (0.39) | ALDH1A1ALOX15KDM4EGAAMAPT | |
| Water SCHEMBL28094977 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11038137-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-06-15 | — | — | US | disclosed |
| US-10790455-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10790455-B2 | Organic electroluminescent materials and devices | ORC3, ALKBH2, ENPP3 | ALDH1A1 2253/4885ALOX15 1857/4885MAPK10 2522/4885 |
| US-11038137-B2 | Organic electroluminescent materials and devices | ORC3, NUDC, AOC1 | ALDH1A1 2725/4885ALOX15 999/4885MAPK10 2097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.